| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 1085 |
| 1 | AFLIBERCEPT | 1021 |
| 2 | ADALIMUMAB | 858 |
| 3 | PREDNISONE | 502 |
| 4 | BROLUCIZUMAB | 447 |
| 5 | METHOTREXATE SODIUM | 414 |
| 6 | METHOTREXATE | 377 |
| 7 | FARICIMAB | 360 |
| 8 | ETANERCEPT | 326 |
| 9 | ERGOCALCIFEROL | 314 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AVANAFIL | 12 | 0.1714 |
| 1 | TETRACAINE HCL | 5 | 0.1429 |
| 2 | TRAVOPROST INTRACAMERAL | 13 | 0.1102 |
| 3 | BALANCED SALT SOLUTION | 100 | 0.0773 |
| 4 | BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE | 19 | 0.0518 |
| 5 | FARICIMAB | 360 | 0.0406 |
| 6 | AVACINCAPTAD PEGOL | 14 | 0.0398 |
| 7 | VORETIGENE NEPARVOVEC-RZYL | 6 | 0.0395 |
| 8 | PEGCETACOPLAN | 72 | 0.0379 |
| 9 | PROPARACAINE HYDROCHLORIDE | 20 | 0.0375 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1418 |
| 1 | Corticosteroid [EPC] | 1167 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1085 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 718 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 658 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 377 |
| 6 | Prostaglandin Analog [EPC] | 329 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 321 |
| 8 | Provitamin D2 Compound [EPC] | 314 |
| 9 | Vitamin C [EPC] | 309 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cyclooxygenase Inhibitor [EPC] | 2 | 0.0244 |
| 1 | Interleukin-5 Antagonist [EPC] | 12 | 0.0174 |
| 2 | Recombinant Human Nerve Growth Factor [EPC] | 214 | 0.0159 |
| 3 | Antiseptic [EPC] | 69 | 0.0158 |
| 4 | Polyene Antimicrobial [EPC] | 5 | 0.0122 |
| 5 | Bispecific HER2-directed Antibody [EPC] | 1 | 0.0122 |
| 6 | Adrenocorticotropic Hormone [EPC] | 10 | 0.0112 |
| 7 | Provitamin D2 Compound [EPC] | 314 | 0.0106 |
| 8 | Quinolone Antimicrobial [EPC] | 90 | 0.0091 |
| 9 | Plasma Volume Expander [EPC] | 28 | 0.0090 |